文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021.

作者信息

Zhang Tai, Zhang Beihua, Tian Wende, Wang Fengyun, Zhang Jiaqi, Ma Xiangxue, Wei Yuchen, Tang Xudong

机构信息

Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Department of Gastroenterology, Xiyuan Hospital, China Academy of Traditional Chinese Medical Sciences, Beijing, China.

出版信息

Front Pharmacol. 2022 Sep 9;13:951004. doi: 10.3389/fphar.2022.951004. eCollection 2022.


DOI:10.3389/fphar.2022.951004
PMID:36199683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9529236/
Abstract

Ulcerative colitis (UC) is an idiopathic inflammatory bowel disease with repeated relapses and remissions. Despite decades of effort, numerous aspects, including the initiating event and pathogenesis of UC, still remain ambiguous, which requires ongoing investigation. Given the mass of publications on UC, there are multidimensional challenges to evaluating the scientific impact of relevant work and identifying the current foci of the multifaceted disease. Accordingly, herein, we aim to assess the global growth of UC research production, analyze patterns of research areas, and evaluate trends in this area. The Web of Science Core Collection of Clarivate Analytics was searched for articles related to UC published from 2011 to 2021. Microsoft Office Excel 2019 was used to visualize the number of publications over time. Knowledge maps were generated using CiteSpace and VOSviewer to analyze collaborations among countries, institutions, and authors and to present the journey of UC research as well as to reveal the current foci of UC research. A total of 5,088 publications were evaluated in the present study. China had the most publications (1,099, 22.5%). Univ Calif San Diego was the most productive institution (126, 2.48%). William J Sandborn published the greatest number of articles (100, 1.97%). Toshifumi Hibi was the most influential author in the field with a betweenness centrality of 0.53. was identified as the most prolific journal (379, 7.45%). was the most co-cited journal (3,730, 4.02%). "Vedolizumab," "tofacitinib," "," "fecal microbiota transplantation (FMT)," "toll-like receptor 4," and "nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome" were considered the hot topics. In UC research, manuscripts that had high impacts on the scientific community provided an evidence base. UC therapy has entered the era of personalized and precision therapy. As research on FMT, anti-integrin antibodies, Janus kinase inhibitors, and anti-tumor necrosis factor drugs continues to grow, their use in the clinical setting may also expand.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/fbf603f7c2ef/fphar-13-951004-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/2e2c5dd5a088/fphar-13-951004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/111761210188/fphar-13-951004-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/61d031cd3fc6/fphar-13-951004-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/863c99bb99b6/fphar-13-951004-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/c341824f5ad2/fphar-13-951004-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/d1204c9984c8/fphar-13-951004-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/ad59a6ca08c6/fphar-13-951004-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/fbf603f7c2ef/fphar-13-951004-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/2e2c5dd5a088/fphar-13-951004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/111761210188/fphar-13-951004-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/61d031cd3fc6/fphar-13-951004-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/863c99bb99b6/fphar-13-951004-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/c341824f5ad2/fphar-13-951004-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/d1204c9984c8/fphar-13-951004-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/ad59a6ca08c6/fphar-13-951004-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e3/9529236/fbf603f7c2ef/fphar-13-951004-g008.jpg

相似文献

[1]
Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021.

Front Pharmacol. 2022-9-9

[2]
Research trends of omics in ulcerative colitis: A bibliometric analysis.

Front Med (Lausanne). 2023-3-27

[3]
Global research trends in atherosclerosis: A bibliometric and visualized study.

Front Cardiovasc Med. 2022-8-23

[4]
Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study.

Rev Cardiovasc Med. 2022-9-14

[5]
Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study.

Front Med (Lausanne). 2022-6-27

[6]
Macrophages in ulcerative colitis: A perspective from bibliometric and visual analysis.

Heliyon. 2023-9-17

[7]
A Bibliometric Analysis of Atrophic Gastritis From 2011 to 2021.

Front Med (Lausanne). 2022-2-17

[8]
Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis.

Front Pharmacol. 2024-9-13

[9]
Trends in gastroesophageal reflux disease research: A bibliometric and visualized study.

Front Med (Lausanne). 2022-9-29

[10]
Global research trends on the links between the gut microbiota and diabetes between 2001 and 2021: A bibliometrics and visualized study.

Front Microbiol. 2022-9-29

引用本文的文献

[1]
Trends and Hotspots in Nanomedicine Applications for Pain: A Bibliometric Analysis from 1999 to 2024.

ACS Omega. 2025-2-7

[2]
Frontiers and hotspots evolution in cytokine storm: A bibliometric analysis from 2004 to 2022.

Heliyon. 2024-5-10

[3]
A bibliometric analysis of insomnia in adolescent.

Front Psychiatry. 2023-10-25

[4]
Progress on Regulation of NLRP3 Inflammasome by Chinese Medicine in Treatment of Ulcerative Colitis.

Chin J Integr Med. 2023-8

[5]
Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.

Front Immunol. 2022

本文引用的文献

[1]
Washed microbiota transplantation improves the fertility of patients with inflammatory bowel disease.

Chin Med J (Engl). 2022-6-20

[2]
Global research trends of immunotherapy and biotherapy for inflammatory bowel disease: a bibliometric analysis from 2002 to 2021.

Biomed Eng Online. 2022-6-27

[3]
Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery.

Microb Biotechnol. 2022-9

[4]
Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease.

Chin Med. 2022-4-28

[5]
Secondary colon cancer in patients with ulcerative colitis: a systematic review and meta-analysis.

J Gastrointest Oncol. 2021-12

[6]
Refractory ulcerative colitis stabilized by interval washed microbiota transplantation: less is more.

Curr Med Res Opin. 2022-4

[7]
Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis.

Therap Adv Gastroenterol. 2021-12-23

[8]
Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease.

Aliment Pharmacol Ther. 2022-1

[9]
Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study.

BMC Gastroenterol. 2021-7-8

[10]
Epidemiology and clinical course of late onset inflammatory bowel disease.

Minerva Gastroenterol (Torino). 2024-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索